Clin2
NCT06732648Possibly a fitRecruiting

Testing a new drug for severe brain swelling after a large stroke

Severe Cerebral Edema Following Large Hemispheric Infarction

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a new drug called HRS8179 to reduce severe brain swelling after a large stroke. If you have a major stroke on one side of the brain and can start treatment within 10 hours, this study may help prevent dangerous pressure buildup.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
725 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You have a large stroke caused by a blocked artery in the middle of the brain on one side.
  • Your stroke symptoms are severe (NIHSS score 10 or more).
  • Brain scans show a damaged area of about 80 to 160 cubic centimeters.
  • You can start the study drug within 10 hours of your stroke or last known well time.
  • You do not have signs of severe brain swelling (like a shift in the middle of the brain) or bleeding in the brain.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07739160Not yet recruiting· Phase 2
A potential treatment for recent ischemic stroke

This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.

Beijing, Beijing Municipality
NCT06905314Not yet recruiting· Phase 1
Testing a new drug in healthy volunteers

This trial tests a new medicine called HRS-4029 in healthy people to see how safe it is and how the body handles it. It is an early-stage study that may help in developing a treatment for future patients.

Beijing, Beijing Municipality
NCT07514949Not yet recruiting
New skull bone injection for severe stroke treatment

This trial tests a new way to deliver a medication called RK-4 directly into the skull bone marrow to bypass the blood-brain barrier for people with a major stroke on one side of the brain. The goal is to see if this injection is safe and feasible, and it might help reduce damage after a severe stroke.

Beijing
NCT07205328Recruiting· Phase 2
Testing MT200605 for acute ischemic stroke

This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.

Beijing, Beijing Municipality
NCT06961487Enrolling by invitation
Stroke treatment trial for large area brain damage

This trial tests if a procedure to remove a large blood clot from the brain (called a thrombectomy) can help people with severe strokes who have a large damaged area. It is for people who can be treated within 24 hours of their stroke starting.

Palo Alto, California
NCT07396337Recruiting· Phase 2
Study of QHRD106 injection for acute ischemic stroke

This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.

Nanjing, Jiangsu

Hear when a new Severe Cerebral Edema Following Large Hemispheric Infarction trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.